FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Wells Pharmacy, Inc(057193721)" | 70713-218 | 70713-218-06 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | .4 mg/1 mL; 3.6 mg/1 mL; .04 mg/1 mL | 2021-1 | valid | 2026-10-22 | ||
| "Wells Pharmacy, Inc(057193721)" | 70713-218 | 70713-218-05 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | .4 mg/1 mL; 3.6 mg/1 mL; .04 mg/1 mL | 2020-2 | valid | 2026-10-22 | ||
| "Wells Pharmacy, Inc(057193721)" | 70713-218 | 70713-218-06 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | .4 mg/1 mL; 3.6 mg/1 mL; .04 mg/1 mL | 2020-2 | valid | 2026-10-22 | ||
| "Wells Pharmacy, Inc(057193721)" | 70713-218 | 70713-218-06 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | .4 mg/1 mL; 3.6 mg/1 mL; .04 mg/1 mL | 2020-1 | valid | 2026-10-22 | ||
| "Wells Pharmacy, Inc(057193721)" | 70713-218 | 70713-218-05 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | .4 mg/1 mL; 3.6 mg/1 mL; .04 mg/1 mL | 2020-1 | valid | 2026-10-22 | ||
| "Wells Pharmacy, Inc(057193721)" | 70713-218 | 70713-218-05 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | .4 mg/1 mL; 3.6 mg/1 mL; .04 mg/1 mL | 2019-2 | valid | 2026-10-22 |